Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application

被引:647
|
作者
Wang, Yi-Xiang J. [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China
关键词
Liver; Contrast media; iron oxide; SPIO; MRI; Neoplasm; Hepatocellular carcinoma;
D O I
10.3978/j.issn.2223-4292.2011.08.03
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Superparamagnetic iron oxide (SPIO) MR contrast agents are composed of nano-sized iron oxide crystals coated with dextran or carboxydextran. Two SPIO agents are clinically approved, namely: ferumoxides (Feridex in the USA, Endorem in Europe) with a particle size of 120 to 180 nm, and ferucarbotran (Resovist) with a particle size of about 60 nm. The principal effect of the SPIO particles is on T2* relaxation and thus MR imaging is usually performed using T2/T2*- weighted sequences in which the tissue signal loss is due to the susceptibility effects of the iron oxide core. Enhancement on T1-weighted images can also be seen with the smaller Resovist. Both Feridex and Resovist are approved specifically for MRI of the liver. The difference being that Resovist can be administered as a rapid bolus (and thus can be used with both dynamic and delayed imaging), whereas Feridex needs to be administered as a slow infusion and is used solely in delayed phase imaging. In the liver, these particles are sequestered by phagocytic Kupffer cells in normal reticuloendothelial system (RES), but are not retained in lesions lacking Kupffer cells. Consequently, there are significant differences in T2/T2* relaxation between normal tissue and lesions, resulting in increased lesion conspicuity and detectability. SPIO substantially increase the detectability of hepatic metastases. For focal hepatocellular lesions, SPIO-enhanced MR imaging exhibits slightly better diagnostic performance than dynamic CT. A combination of dynamic and static MR imaging technique using T1- and T2 imaging criteria appears to provide clinically more useful patterns of enhancement. Feridex and Resovist are also used for evaluating macrophage activities in some inflammatory lesions, but their clinical values remain to be further confirmed. The clinical development of Ferumoxtran (Combidex in the USA, Sinerem in Europe), designed for lymph node metastasis evaluation, is currently stopped.
引用
收藏
页码:35 / 40
页数:6
相关论文
共 50 条
  • [1] Current status of superparamagnetic iron oxide contrast agents for liver magnetic resonance imaging
    Yi-Xiang J Wang
    World Journal of Gastroenterology, 2015, (47) : 13400 - 13402
  • [2] Current status of superparamagnetic iron oxide contrast agents for liver magnetic resonance imaging
    Wang, Yi-Xiang J.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (47) : 13400 - 13402
  • [3] Peptide functionalized superparamagnetic iron oxide nanoparticles as MRI contrast agents
    Sulek, Selim
    Mammadov, Busra
    Mahcicek, Davut I.
    Sozeri, Huseyin
    Atalar, Ergin
    Tekinay, Ayse B.
    Guler, Mustafa O.
    JOURNAL OF MATERIALS CHEMISTRY, 2011, 21 (39) : 15157 - 15162
  • [4] Zinc superparamagnetic iron oxide nanoparticles for use as MRI contrast agents
    Barcena, Carlos
    Kherntong, Chalermchai
    Chaubey, Girija S.
    Kessinger, Chase W.
    Liu, J. Ping
    Gao, Jinming
    PROCEEDING OF THE ASME SUMMER BIOENGINEERING CONFERENCE - 2007, 2007, : 49 - 50
  • [5] Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin
    Atanasijevic, Tatjana
    Shusteff, Maxim
    Fam, Peter
    Jasanoff, Alan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (40) : 14707 - 14712
  • [6] New MRI contrast agents based on silicon nanotubes loaded with superparamagnetic iron oxide nanoparticles
    Gonzalez-Rodriguez, Roberto
    Granitzer, Petra
    Rumpf, Klemens
    Coffer, Jeffery L.
    ROYAL SOCIETY OPEN SCIENCE, 2018, 5 (08):
  • [7] Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents
    Di Marco, Mariagrazia
    Sadun, Claudia
    Port, Marc
    Guilbert, Irene
    Couvreur, Patrick
    Dubernet, Catherine
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2007, 2 (04): : 609 - 622
  • [8] Ultra-small superparamagnetic iron oxide nanoparticles as MRI contrast enhancing agents
    Do, M. A.
    Lee, H. J.
    Yeum, J. H.
    Chang, Y. M.
    Ghim, H. D.
    Choi, J. H.
    MULTI-FUNCTIONAL MATERIALS AND STRUCTURES, PTS 1 AND 2, 2008, 47-50 : 1076 - +
  • [9] Iron-Based Superparamagnetic Nanoparticle Contrast Agents for MRI of Infection and Inflammation
    Neuwelt, Alexander
    Sidhu, Navneet
    Hu, Chien-An A.
    Mlady, Gary
    Eberhardt, Steven C.
    Sillerud, Laurel O.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2015, 204 (03) : W302 - W313
  • [10] Magnetic Resonance Imaging Contrast Agents Based on Iron Oxide Superparamagnetic Ferrofluids
    Casula, Maria F.
    Floris, Patrizia
    Innocenti, Claudia
    Lascialfari, Alessandro
    Marinone, Massimo
    Corti, Maurizio
    Sperling, Ralph A.
    Parak, Wolfgang J.
    Sangregorio, Claudio
    CHEMISTRY OF MATERIALS, 2010, 22 (05) : 1739 - 1748